Biotech · Private company · Research Triangle Park, NC, US
Epicypher, Inc.
Track this companyFree. Adds Epicypher, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- Scalable, single-molecule and single-cell chromatin accessibility profiling in primary immune cellsFiscal year 2026 · $999.3KNIH RePORTER 1R44AI197362-01 · fetched Nov 12, 2026
- Genomic profiling of drug-chromatin interactions for accelerated drug development researchFiscal year 2026 · $1.1MNIH RePORTER 1R44TR006068-01A1 · fetched Nov 12, 2026
- Development of novel epigenetic biomarkers and detection reagents for agingFiscal year 2026 · $1.2MNIH RePORTER 5R44AG091990-02 · fetched Nov 12, 2026
- Epigenomic analysis of cell-free nucleosomes for cancer researchFiscal year 2026 · $1MNIH RePORTER 5R44CA284973-03 · fetched Nov 12, 2026
- Asymmetric nucleosome substrates to advance the study of the histone codeFiscal year 2026 · $1.3MNIH RePORTER 5R44GM154510-02 · fetched Nov 12, 2026
- Development of novel epigenetic biomarkers and detection reagents for agingFiscal year 2025 · $1.2MNIH RePORTER 1R44AG091990-01 · fetched Nov 12, 2026
- Asymmetric nucleosome substrates to advance the study of the histone codeFiscal year 2025 · $1.3MNIH RePORTER 1R44GM154510-01A1 · fetched Nov 12, 2026
- Epigenomic analysis of cell-free nucleosomes for cancer researchFiscal year 2025 · $1MNIH RePORTER 2R44CA284973-02 · fetched Nov 12, 2026
- Versatile genomics platform for unbiased analysis of chromatin-associated RNAs and nascent transcriptsFiscal year 2025 · $1.3MNIH RePORTER 5R44AG087752-02 · fetched Nov 12, 2026
- Versatile platform for genome-wide R-loop mapping for aging and neurodegenerative disease researchFiscal year 2025 · $1.3MNIH RePORTER 5R44AG090112-02 · fetched Nov 12, 2026